Stay updated with breaking news from Assay Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data Bridge Market Research Published Latest Hepatocellular Carcinoma Drugs Market Study with an in-depth analysis of the current scenario, the Market size,
/PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Medical Linear Accelerator Market" The report offers an extensive...
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Human Leukocyte Antigen Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.
Waters Corporation has introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.